The courses below will help you better understand COVID-19 guidelines and how to manage COVID-19 diagnostics and treatment.

ATTENTION! - To attend the classes below or track your completed courses, please login or register to the ASLM Academy.




View the latest training materials on ASLM's COVID-19 Antigen testing.

ASLM’s COVID-19 ECHO Sessions

View the latest of ASLM’S COVID-19 ECHO SESSIONS

Session 1

Troubleshooting Common Challenges Associated with SARS-CoV-2 Diagnostic Test Establishment

Session 2

Latest Update On Available Technology to Detect COVID-19

Session 3

The Korean Experience for the African Continent

Session 4

Manufacturers of COVID-19 Molecular Diagnostic Tests: BD and Cepheid

Session 5

Manufacturers of COVID-19 Molecular Diagnostic Tests: QIAGEN & Thermo Fisher Scientific

Session 6

Serology Tests and Their Role in the Pandemic Response

Session 7

Implementing Fast Turn-Around Laboratory Testing for Control of COVID-19

Session 8

Manufacturers of Molecular Diagnostics Tests Pt3: Abbott and Bio-Rad

Session 9

Diagnostics in the COVID-19 Pandemic Response

Session 10

Best Practices Implementing a Structured Quality Assured Testing Program

Session 11

Procurement and Supply Chain for COVID-19 Diagnostics

Session 12

Facial Masks During COVID-19: Homemaking, Disinfection and Imaging

May 2020 Waste Management Training

COVID-19 Biosafety Guidance for Laboratories Confirmation

Session 13

Manufacturers of COVID-19 Molecular Diagnostics Tests: Abbott Serology in the Core Lab and Analytics

Session 14

Specimen Referral Systems for SARS-CoV-2 Testing

Session 15

Manufacturers of COVID-19 Molecular Diagnostics Tests: KH Medical Co., Ltd., South Korea & Inqaba Biotec

Session 16

Manufacturers of COVID-19 Molecular Diagnostics Tests: PerkinElmer & Pro-Med Diagnostics, South Africa

June 2020 LabCoP ECHO Session

Key Considerations for Differentiated Service Delivery in the Context of the Global COVID-19 Pandemic

Session 17

Manufacturers of COVID-19 Molecular Diagnostics Tests: EUROIMMUN AG, Germany and Hologic, USA

Session 18

Manufacturers of COVID-19 Molecular Diagnostics Tests: Roche Diagnostics International Ltd.

Session 19

Public Health Lab Networks and SARS-CoV-2 Testing: Challenges, Strategies, and Lessons from the USA

July 2020 LabCoP ECHO Session

No Time to Wait! Demand Creation for Early Infant Diagnosis of HIV

Session 20

Laboratory Data Management Considerations for COVID-19 Response

Session 21

Optimised Diagnostic Networks Key to Responding to COVID-19: Doing More with Less

August 2020 LabCoP ECHO Session

EQA Proficiency Testing Coverage, Results and Sustainability from the Perspective of a Service Provider

Special LabCoP ECHO Session

Establishing Diagnostic Connectivity for Laboratory Network Data Flow Across Conventional & POC Systems

Session 22

Self-Collection of Nasal Specimens: Lowering the Barrier to SARS-CoV-2 Testing and Access to Care

Session 23

COVID-19 Antigen Testing’s Role in the Helping Control the Pandemic

September 2020 LabCoP ECHO Session

Using Strategic Communications as a Tool for Social Change and Advocacy

Session 24

COVID-19 Testing Project – Independent Evaluation Results: What Do We Know About Performance?

Session 25

Considerations of Pooling Specimens for COVID-19 Testing by Real-Time RT-PCR

Session 26

Unpacking the Global Launch of COVID-19 Ag-RDT Testing

Session 27

Digital solutions supporting healthcare providers and stakeholders in their COVID-19 response

Session 28

Manufacturers of COVID-19 Rapid Diagnostics Tests: Abbott Panbio SARS-CoV-2 Antigen Rapid Test

Session 29

Manufacturers of COVID-19 Rapid Diagnostics Tests: STANDARD Q COVID-19 Antigen Rapid Test

Session 30

Funding & Procurement Mechanisms for SARS-CoV-2 Antigen Rapid Tests

October 2020 LabCoP ECHO session on 29 October

Operationalising the M&E Sub-community of Practice: Improving M&E for HIV/TB and Emerging Challenges

Session 31

Manufacturers of COVID-19 Rapid Diagnostics Tests: LumiraDx SARS-CoV-2 Antigen Assay

Session 32

Launch of SARS-CoV-2 Antigen Rapid Test Training Package

COVID-19 Diagnostics Training MOOC

Learn about the latest recommendations on COVID-19 diagnostics and testing from Future Learn



Frequently Asked Questions (FAQs)

  1. What is the SARS-COV-2 antigen rapid diagnostic test training package?

The training package is a set of training materials and supplementary resources developed and made by ASLM in collaboration with partners to provide guidance and information on the use of antigen rapid diagnostic tests (RDTs) for the diagnosis of COVID-19. The RDTs referenced in the training include both lateral flow and device-based tests. The overall goal of these training materials is to support the scale-up of SARS-COV-2 testing in member states by creating an accessible, adaptable and thorough training package.

  1. Who is the target audience for the SARS-COV-2 antigen rapid diagnostic test training package?

The ultimate audience for the training is frontline healthcare workers and other end user service providers engaged in COVID-19 testing.

Materials are packaged into a training of trainers (ToT) set that may be used by trainers to deliver training to end users.

In addition, governments entities (e.g. Ministries of Health, National COVID-19 Task Forces) of members states, funding agencies, and development partners may use the overview and training materials to plan for training in the context of scale-up.

  1. What is the duration of this SARS-COV-2 antigen rapid diagnostic test training?

The suggested length of training is three days, consisting of two days of didactic/theory training with one day dedicated for practical sessions.

The duration can be adjusted and modified accordingly depending on the in-country local needs but should not exceed five days.

  1. May participants receive certificates after completing this SARS-COV-2 antigen rapid diagnostic test training?

Yes. To receive the training certificate, participants must have attended 100% of the didactic/theory training sessions and score at least 80% and 100% in the theory and practical assessments respectively, as evaluated by a trainer.

Trainers should email with the completed certificate registration form which is located in the downloadable training package. Participants will be verified and sent ASLM certificates to their email.

  1. How does one access the SARS-COV-2 Antigen rapid diagnostic test training package?

You are required to register and login to download the materials.

A training overview intended for Ministries of Health and other policy-making audiences is available for all.

The full set of training materials are meant for ToTs and trainers but can be accessed by all. Assessments and certification forms are limited to trainers and can be accessed using an authentication code that will be made available via your country laboratory leadership. For more information and requests for accessing the assessments please email Silver Mashate at